These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23795817)

  • 1. Medical management of critical limb ischaemia: where do we stand today?
    Lambert MA; Belch JJ
    J Intern Med; 2013 Oct; 274(4):295-307. PubMed ID: 23795817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter III: Management of cardiovascular risk factors and medical therapy.
    Diehm N; Schmidli J; Setacci C; Ricco JB; de Donato G; Becker F; Robert-Ebadi H; Cao P; Eckstein HH; De Rango P; Teraa M; Moll FL; Dick F; Davies AH; Lepäntalo M; Apelqvist J
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S33-42. PubMed ID: 22172471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical limb ischaemia.
    Minar E
    Hamostaseologie; 2009 Jan; 29(1):102-9. PubMed ID: 19151858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.
    Sen I; Agarwal S; Tharyan P; Forster R
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009366. PubMed ID: 29658630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.
    Norgren L; Patel MR; Hiatt WR; Wojdyla DM; Fowkes FGR; Baumgartner I; Mahaffey KW; Berger JS; Jones WS; Katona BG; Held P; Blomster JI; Rockhold FW; Björck M;
    Eur J Vasc Endovasc Surg; 2018 Jan; 55(1):109-117. PubMed ID: 29273390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial disease.
    Karanth VK; Karanth TK; Karanth L
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011519. PubMed ID: 27959471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment.
    Sprengers RW; Teraa M; Moll FL; de Wit GA; van der Graaf Y; Verhaar MC; ;
    J Vasc Surg; 2010 Oct; 52(4):843-9, 849.e1. PubMed ID: 20598482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter IV: Treatment of critical limb ischaemia.
    Setacci C; de Donato G; Teraa M; Moll FL; Ricco JB; Becker F; Robert-Ebadi H; Cao P; Eckstein HH; De Rango P; Diehm N; Schmidli J; Dick F; Davies AH; Lepäntalo M; Apelqvist J
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S43-59. PubMed ID: 22172473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal.
    Lawall H; Bramlage P; Amann B
    Thromb Haemost; 2010 Apr; 103(4):696-709. PubMed ID: 20174766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy in critical limb ischemia: update on clopidogrel and cilostazol.
    Spiliopoulos S
    J Cardiovasc Surg (Torino); 2014 Oct; 55(5):631-40. PubMed ID: 24866775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive aspects in peripheral artery disease.
    Aggarwal S; Loomba RS; Arora R
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):53-70. PubMed ID: 22337767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR
    J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    ; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
    N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
    de Donato G; Gussoni G; de Donato G
    Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing risk factors for atherosclerosis in critical limb ischaemia.
    Gottsäter A
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):478-83. PubMed ID: 16631394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.
    Conte MS; Bandyk DF; Clowes AW; Moneta GL; Namini H; Seely L
    J Vasc Surg; 2005 Sep; 42(3):456-64; discussion 464-5. PubMed ID: 16171587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.